I think it’s a good thing. Let’s face it she wasn’t adding any value whatsoever at this point.
Personally I’d like to see JAMES disappear as well to be honest. Never responds to anything these days but I think some fresh people in the company be a very positive thing particularly getting to clinical trials. JAMES has not presented well in this case.
He’s the type of doctor that will be stupid enough to do a capital raise this quarter and then question why it failed.
Ann: Retirement of Non-Executive Director, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $2.951K | 479.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2826219 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1128726 | 3 |
View Market Depth
| Last trade - 13.41pm 30/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |